20-Jan-2017 - The financial press is rife with chatter that Nestle is weighing up a bid for US infant formula firm Mead Johnson.
While long treasured for its medicinal properties in Asia, a new Taiwanese review has drawn attention to four species of the fungi Cordyceps, highlighting the mushrooms’ potential as a functional food targeting metabolic, liver, sexual, and bone/joint disorders.
The global nutraceuticals market is expected to reach a value of $302,306m by the year 2022, on the back of CAGR of 7.04%. But, according to new research, APAC is poised to outstrip the global growth average.
Modulation of gut microbiota through personalised diet or probiotic intervention will increasingly become a key focus for treating brain disorders including Alzheimer’s Disease, Chinese academics have concluded in a new review.
Chinese supplier BGG’s has won EU novel foods approval for two astaxanthin forms through its new European HQ in Lugano, Switzerland.
Chicoric acid (CA), a nutraceutical component from the chicory plant, could slow down memory loss associated with Alzheimer’s and other neurodegenerative diseases, a study revealed.